If you or someone you know purchased unapproved eye products from any of the companies addressed below, and experienced any adverse reaction, Please Click Here, call us at (914) 298-3283, or email us firstname.lastname@example.org to discuss your legal options.
The U.S. Food and Drug Administration (“FDA”) on September 12, 2023 issued warning letters to eight companies, including Boiron Inc., CVS Health, DR Vitamin Solutions, Natural Ophthalmics, Inc., OcluMed LLC, Similasan AG/Similasan USA, TRP Company, Inc., and Walgreens Boots Alliance, Inc., for manufacturing or marketing unapproved eye products.
The FDA is particularly concerned that these illegally marketed, unapproved ophthalmic drug products pose a heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses.
Eye products addressed in the eight warning letters are illegally marketed to treat conditions such as conjunctivitis (“pink eye”), cataracts, glaucoma and others. Some of these eye products are labeled to contain silver, the FDA said, adding that long-term use of drugs containing silver can cause some areas of the skin and other body tissues, including in the eye, to permanently turn gray or blue-gray. The FDA’s investigation of eye products is ongoing.
The attorneys at Finkelstein, Blankinship, Frei-Pearson & Garber, LLP have successfully prosecuted numerous consumer protection actions. If you or someone you know experienced any adverse reaction after using unapproved eye products from these companies, please contact us immediately so we can discuss this matter with you.
To contact us please fill in the webform on this page.
We will review the information and an attorney will contact you shortly.
You can also call us toll free at 844-431-0695